V. Watts

Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.

V. Watts, M. Cumbay, V. Watts, 2001, The Journal of pharmacology and experimental therapeutics.

Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.

D. Lysle, V. Watts, L. Dykstra, 1993, The Journal of pharmacology and experimental therapeutics.

Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor.

K. Neve, K. Thompson, M. Teeter, 2001, Molecular pharmacology.

Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.

R. Mailman, V. Watts, M. Lewis, 1998, The Journal of pharmacology and experimental therapeutics.

(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling

Amy E. Moritz, R. Free, T. Doyle, 2014, Psychopharmacology.

Comparison of the enantiomers of (±)-doxanthrine, a high efficacy full dopamine D1 receptor agonist, and a reversal of enantioselectivity at D1 versus alpha2C adrenergic receptors

J. A. Chester, Julie A. Przybyla, V. Watts, 2009, European Neuropsychopharmacology.